
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
EAGLE PHARMACEUTI.DL-,001 1E6 US2697961082 BAW/UFN
© 2024 Xetra Newsboard
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mo | Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA Royalties | WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the "Company" or "Eagle") today announced that it has entered into a royalty purchase agreement... ► Artikel lesen | |
21.03. | Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan | WOODCLIFF LAKE, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the "Company" or "Eagle") today announced that its Board of Directors (the "Board") has approved... ► Artikel lesen | |
24.01. | EAGLE PHARMACEUTICALS, INC. - 15-12G, Securities registration termination | ||
27.11.24 | EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report | ||
26.11.24 | EAGLE PHARMACEUTICALS, INC. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |